{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T14:11:55Z","timestamp":1771078315154,"version":"3.50.1"},"reference-count":88,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,8,15]]},"DOI":"10.7759\/cureus.66955","type":"journal-article","created":{"date-parts":[[2024,8,15]],"date-time":"2024-08-15T18:06:35Z","timestamp":1723745195000},"source":"Crossref","is-referenced-by-count":1,"title":["Unraveling the Missing Pieces: Exploring the Gaps in Understanding Chagas Cardiomyopathy"],"prefix":"10.7759","author":[{"given":"Keerthana","family":"Veluswami","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sudipta","family":"Rao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shailesh","family":"Aggarwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sweatha","family":"Mani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abirami","family":"Balasubramanian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)60061-X","article-title":"Chagas disease","volume":"375","author":"Rassi A Jr","year":"2010","unstructured":"Rassi A Jr, Rassi A, Marin-Neto JA. Chagas disease. Lancet. 2010, 375:1388-402. 10.1016\/S0140-6736(10)60061-X","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.5334\/gh.484","article-title":"WHF IASC roadmap on Chagas disease","volume":"15","author":"Echeverr\u00eda LE","year":"2020","unstructured":"Echeverr\u00eda LE, Marcus R, Novick G, et al.. WHF IASC roadmap on Chagas disease. Glob Heart. 2020, 15:26. 10.5334\/gh.484","journal-title":"Glob Heart"},{"key":"ref3","unstructured":"Chagas disease (also known as American trypanosomiasis). (2024). Accessed. April 29, 2024: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/chagas-disease-(american-trypanosomiasis)."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.4330\/wjc.v13.i12.654","article-title":"Chagas heart disease: an overview of diagnosis, manifestations, treatment, and care","volume":"13","author":"Saraiva RM","year":"2021","unstructured":"Saraiva RM, Mediano MF, Mendes FS, et al.. Chagas heart disease: an overview of diagnosis, manifestations, treatment, and care. World J Cardiol. 2021, 13:654-75. 10.4330\/wjc.v13.i12.654","journal-title":"World J Cardiol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1590\/s0074-02762007005000093","article-title":"Epidemiology of Chagas disease in non-endemic countries: the role of international migration","volume":"102 Suppl 1","author":"Schmunis GA","year":"2007","unstructured":"Schmunis GA. Epidemiology of Chagas disease in non-endemic countries: the role of international migration. Mem Inst Oswaldo Cruz. 2007, 102 Suppl 1:75-85. 10.1590\/s0074-02762007005000093","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00005-11","article-title":"Trypanosoma cruzi and Chagas' Disease in the United States","volume":"24","author":"Bern C","year":"2011","unstructured":"Bern C, Kjos S, Yabsley MJ, Montgomery SP. Trypanosoma cruzi and Chagas' Disease in the United States. Clin Microbiol Rev. 2011, 24:655-81. 10.1128\/CMR.00005-11","journal-title":"Clin Microbiol Rev"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000599","article-title":"Chagas cardiomyopathy: an update of current clinical knowledge and management: a scientific statement from the American Heart Association","volume":"138","author":"Nunes MC","year":"2018","unstructured":"Nunes MC, Beaton A, Acquatella H, et al.. Chagas cardiomyopathy: an update of current clinical knowledge and management: a scientific statement from the American Heart Association. Circulation. 2018, 138:e169-209. 10.1161\/CIR.0000000000000599","journal-title":"Circulation"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1590\/s0074-02761999000700007","article-title":"Immunopathology of Chagas disease","volume":"94 Suppl 1","author":"Andrade ZA","year":"1999","unstructured":"Andrade ZA. Immunopathology of Chagas disease. Mem Inst Oswaldo Cruz. 1999, 94 Suppl 1:71-80. 10.1590\/s0074-02761999000700007","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2013.05.046","article-title":"Chagas disease: an overview of clinical and epidemiological aspects","volume":"62","author":"Nunes MC","year":"2013","unstructured":"Nunes MC, Dones W, Morillo CA, Encina JJ, Ribeiro AL. Chagas disease: an overview of clinical and epidemiological aspects. J Am Coll Cardiol. 2013, 62:767-76. 10.1016\/j.jacc.2013.05.046","journal-title":"J Am Coll Cardiol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens10050505","article-title":"Chagas cardiomyopathy: From Roma\u00f1a sign to heart failure and sudden cardiac death","volume":"10","author":"Pino-Mar\u00edn A","year":"2021","unstructured":"Pino-Mar\u00edn A, Medina-Rinc\u00f3n GJ, Gallo-Bernal S, et al.. Chagas cardiomyopathy: From Roma\u00f1a sign to heart failure and sudden cardiac death. Pathogens. 2021, 10:505. 10.3390\/pathogens10050505","journal-title":"Pathogens"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/849504","article-title":"Treatment of Chagas cardiomyopathy","volume":"2013","author":"Botoni FA","year":"2013","unstructured":"Botoni FA, Ribeiro AL, Marinho CC, Lima MM, Nunes Mdo C, Rocha MO. Treatment of Chagas cardiomyopathy. Biomed Res Int. 2013, 2013:849504. 10.1155\/2013\/849504","journal-title":"Biomed Res Int"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s12350-018-1361-1","article-title":"Chagas heart disease: a contemporary review","volume":"27","author":"Velasco A","year":"2020","unstructured":"Velasco A, Morillo CA. Chagas heart disease: a contemporary review. J Nucl Cardiol. 2020, 27:445-51. 10.1007\/s12350-018-1361-1","journal-title":"J Nucl Cardiol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.106.624296","article-title":"Pathogenesis of chronic Chagas heart disease","volume":"115","author":"Marin-Neto JA","year":"2007","unstructured":"Marin-Neto JA, Cunha-Neto E, Maciel BC, Sim\u00f5es MV. Pathogenesis of chronic Chagas heart disease. Circulation. 2007, 115:1109-23. 10.1161\/CIRCULATIONAHA.106.624296","journal-title":"Circulation"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/s0008-6363(03)00361-4","article-title":"Pathophysiology of the heart in Chagas' disease: current status and new developments","volume":"60","author":"Higuchi Mde L","year":"2003","unstructured":"Higuchi Mde L, Benvenuti LA, Martins Reis M, Metzger M. Pathophysiology of the heart in Chagas' disease: current status and new developments. Cardiovasc Res. 2003, 60:96-107. 10.1016\/s0008-6363(03)00361-4","journal-title":"Cardiovasc Res"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/s0046-8177(00)80191-4","article-title":"Cardiac autonomic denervation in congestive heart failure: comparison of Chagas' heart disease with other dilated cardiomyopathy","volume":"31","author":"Machado CR","year":"2000","unstructured":"Machado CR, Camargos ER, Guerra LB, Moreira MC. Cardiac autonomic denervation in congestive heart failure: comparison of Chagas' heart disease with other dilated cardiomyopathy. Hum Pathol. 2000, 31:3-10. 10.1016\/s0046-8177(00)80191-4","journal-title":"Hum Pathol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/0167-5273(96)02592-2","article-title":"Antiadrenergic and muscarinic receptor antibodies in Chagas' cardiomyopathy","volume":"54","author":"Borda ES","year":"1996","unstructured":"Borda ES, Sterin-Borda L. Antiadrenergic and muscarinic receptor antibodies in Chagas' cardiomyopathy. Int J Cardiol. 1996, 54:149-56. 10.1016\/0167-5273(96)02592-2","journal-title":"Int J Cardiol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/s0167-5273(96)02878-1","article-title":"Sudden and unexpected death in clinically 'silent' Chagas' disease. A hypothesis","volume":"58","author":"Baroldi G","year":"1997","unstructured":"Baroldi G, Oliveira SJ, Silver MD. Sudden and unexpected death in clinically 'silent' Chagas' disease. A hypothesis. Int J Cardiol. 1997, 58:263-8. 10.1016\/s0167-5273(96)02878-1","journal-title":"Int J Cardiol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.55.2.204","article-title":"Effect of parasympathetic impairment on the haemodynamic response to handgrip in Chagas's heart disease","volume":"55","author":"Marin-Neto JA","year":"1986","unstructured":"Marin-Neto JA, Maciel BC, Gallo J\u00fanior L, Junqueira J\u00fanior LF, Amorim DS. Effect of parasympathetic impairment on the haemodynamic response to handgrip in Chagas's heart disease. Br Heart J. 1986, 55:204-10. 10.1136\/hrt.55.2.204","journal-title":"Br Heart J"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1113\/expphysiol.2012.066381","article-title":"Autonomic neuroimmunomodulation in chagasic cardiomyopathy","volume":"97","author":"Ribeiro Machado MP","year":"2012","unstructured":"Ribeiro Machado MP, Dias da Silva VJ. Autonomic neuroimmunomodulation in chagasic cardiomyopathy. Exp Physiol. 2012, 97:1151-60. 10.1113\/expphysiol.2012.066381","journal-title":"Exp Physiol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9149(00)01133-4","article-title":"Relation of regional sympathetic denervation and myocardial perfusion disturbance to wall motion impairment in Chagas' cardiomyopathy","volume":"86","author":"Sim\u00f5es MV","year":"2000","unstructured":"Sim\u00f5es MV, Pintya AO, Bromberg-Marin G, et al.. Relation of regional sympathetic denervation and myocardial perfusion disturbance to wall motion impairment in Chagas' cardiomyopathy. Am J Cardiol. 2000, 86:975-81. 10.1016\/s0002-9149(00)01133-4","journal-title":"Am J Cardiol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11247262","article-title":"Chagas heart disease: beyond a single complication, from asymptomatic disease to heart failure","volume":"11","author":"Montalvo-Ocotoxtle IG","year":"2022","unstructured":"Montalvo-Ocotoxtle IG, Rojas-Velasco G, Rodr\u00edguez-Morales O, et al.. Chagas heart disease: beyond a single complication, from asymptomatic disease to heart failure. J Clin Med. 2022, 11:7262. 10.3390\/jcm11247262","journal-title":"J Clin Med"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1172\/JCI112266","article-title":"A neuraminidase from Trypanosoma cruzi removes sialic acid from the surface of mammalian myocardial and endothelial cells","volume":"77","author":"Libby P","year":"1986","unstructured":"Libby P, Alroy J, Pereira ME. A neuraminidase from Trypanosoma cruzi removes sialic acid from the surface of mammalian myocardial and endothelial cells. J Clin Invest. 1986, 77:127-35. 10.1172\/JCI112266","journal-title":"J Clin Invest"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1590\/0037-8682-0028-2013","article-title":"Pathogenesis of chronic Chagas cardiomyopathy: the role of coronary microvascular derangements","volume":"46","author":"Marin-Neto JA","year":"2013","unstructured":"Marin-Neto JA, Sim\u00f5es MV, Rassi Junior A. Pathogenesis of chronic Chagas cardiomyopathy: the role of coronary microvascular derangements. Rev Soc Bras Med Trop. 2013, 46:536-41. 10.1590\/0037-8682-0028-2013","journal-title":"Rev Soc Bras Med Trop"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pathol-020117-043711","article-title":"Pathology and pathogenesis of Chagas heart disease","volume":"14","author":"Bonney KM","year":"2019","unstructured":"Bonney KM, Luthringer DJ, Kim SA, Garg NJ, Engman DM. Pathology and pathogenesis of Chagas heart disease. Annu Rev Pathol. 2019, 14:421-47. 10.1146\/annurev-pathol-020117-043711","journal-title":"Annu Rev Pathol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.2174\/156652408785748004","article-title":"Chagas heart disease pathogenesis: one mechanism or many?","volume":"8","author":"Bonney KM","year":"2008","unstructured":"Bonney KM, Engman DM. Chagas heart disease pathogenesis: one mechanism or many?. Curr Mol Med. 2008, 8:510-8. 10.2174\/156652408785748004","journal-title":"Curr Mol Med"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/1054-8807(93)90021-S","article-title":"Correlation between Trypanosoma cruzi parasitism and myocardial inflammatory infiltrate in human chronic chagasic myocarditis: Light microscopy and immunohistochemical findings","volume":"2","author":"Higuchi Mde L","year":"1993","unstructured":"Higuchi Mde L, De Brito T, Martins Reis M, Barbosa A, Bellotti G, Pereira-Barreto AC, Pileggi F. Correlation between Trypanosoma cruzi parasitism and myocardial inflammatory infiltrate in human chronic chagasic myocarditis: Light microscopy and immunohistochemical findings. Cardiovasc Pathol. 1993, 2:101-6. 10.1016\/1054-8807(93)90021-S","journal-title":"Cardiovasc Pathol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-8703(96)90358-0","article-title":"In vivo detection of Trypanosoma cruzi antigens in hearts of patients with chronic Chagas' heart disease","volume":"131","author":"Bellotti G","year":"1996","unstructured":"Bellotti G, Bocchi EA, de Moraes AV, et al.. In vivo detection of Trypanosoma cruzi antigens in hearts of patients with chronic Chagas' heart disease. Am Heart J. 1996, 131:301-7. 10.1016\/s0002-8703(96)90358-0","journal-title":"Am Heart J"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1080\/08916930500485002","article-title":"Induction of cardiac autoimmunity in Chagas heart disease: a case for molecular mimicry","volume":"39","author":"Cunha-Neto E","year":"2006","unstructured":"Cunha-Neto E, Bilate AM, Hyland KV, Fonseca SG, Kalil J, Engman DM. Induction of cardiac autoimmunity in Chagas heart disease: a case for molecular mimicry. Autoimmunity. 2006, 39:41-54. 10.1080\/08916930500485002","journal-title":"Autoimmunity"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1084\/jem.182.1.59","article-title":"Molecular mimicry between the immunodominant ribosomal protein P0 of Trypanosoma cruzi and a functional epitope on the human beta 1-adrenergic receptor","volume":"182","author":"Ferrari I","year":"1995","unstructured":"Ferrari I, Levin MJ, Wallukat G, et al.. Molecular mimicry between the immunodominant ribosomal protein P0 of Trypanosoma cruzi and a functional epitope on the human beta 1-adrenergic receptor. J Exp Med. 1995, 182:59-65. 10.1084\/jem.182.1.59","journal-title":"J Exp Med"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.92.8.3541","article-title":"Autoimmunity in Chagas disease cardiopathy: biological relevance of a cardiac myosin-specific epitope crossreactive to an immunodominant Trypanosoma cruzi antigen","volume":"92","author":"Cunha-Neto E","year":"1995","unstructured":"Cunha-Neto E, Duranti M, Gruber A, et al.. Autoimmunity in Chagas disease cardiopathy: biological relevance of a cardiac myosin-specific epitope crossreactive to an immunodominant Trypanosoma cruzi antigen. Proc Natl Acad Sci U S A. 1995, 92:3541-5. 10.1073\/pnas.92.8.3541","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/14.3.299","article-title":"The Trypanosoma cruzi trans-sialidase is a T cell-independent B cell mitogen and an inducer of non-specific Ig secretion","volume":"14","author":"Gao W","year":"2002","unstructured":"Gao W, Wortis HH, Pereira MA. The Trypanosoma cruzi trans-sialidase is a T cell-independent B cell mitogen and an inducer of non-specific Ig secretion. Int Immunol. 2002, 14:299-308. 10.1093\/intimm\/14.3.299","journal-title":"Int Immunol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1038\/78651","article-title":"A B-cell mitogen from a pathogenic trypanosome is a eukaryotic proline racemase","volume":"6","author":"Reina-San-Mart\u00edn B","year":"2000","unstructured":"Reina-San-Mart\u00edn B, Degrave W, Rougeot C, et al.. A B-cell mitogen from a pathogenic trypanosome is a eukaryotic proline racemase. Nat Med. 2000, 6:890-7. 10.1038\/78651","journal-title":"Nat Med"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00926-09","article-title":"Genetic immunization converts the trypanosoma cruzi B-Cell mitogen proline racemase to an effective immunogen","volume":"78","author":"Bryan MA","year":"2010","unstructured":"Bryan MA, Norris KA. Genetic immunization converts the trypanosoma cruzi B-Cell mitogen proline racemase to an effective immunogen. Infect Immun. 2010, 78:810-22. 10.1128\/IAI.00926-09","journal-title":"Infect Immun"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00423-07","article-title":"Modulation of autoimmunity by treatment of an infectious disease","volume":"75","author":"Hyland KV","year":"2007","unstructured":"Hyland KV, Leon JS, Daniels MD, et al.. Modulation of autoimmunity by treatment of an infectious disease. Infect Immun. 2007, 75:3641-50. 10.1128\/IAI.00423-07","journal-title":"Infect Immun"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-3024.2000.00260.x","article-title":"Chagasic patients develop a type 1 immune response to Trypanosoma cruzi trans-sialidase","volume":"22","author":"Ribeir\u00e3o M","year":"2000","unstructured":"Ribeir\u00e3o M, Pereira-Chioccola VL, R\u00e9nia L, Augusto Fragata Filho A, Schenkman S, Rodrigues MM. Chagasic patients develop a type 1 immune response to Trypanosoma cruzi trans-sialidase. Parasite Immunol. 2000, 22:49-53. 10.1046\/j.1365-3024.2000.00260.x","journal-title":"Parasite Immunol"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1006\/jaut.2001.0523","article-title":"Chronic Chagas' disease cardiomyopathy patients display an increased IFN-gamma response to Trypanosoma cruzi infection","volume":"17","author":"Abel LC","year":"2001","unstructured":"Abel LC, Rizzo LV, Ianni B, et al.. Chronic Chagas' disease cardiomyopathy patients display an increased IFN-gamma response to Trypanosoma cruzi infection. J Autoimmun. 2001, 17:99-107. 10.1006\/jaut.2001.0523","journal-title":"J Autoimmun"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.71.3.1185-1193.2003","article-title":"Evidence that development of severe cardiomyopathy in human Chagas' disease is due to a Th1-specific immune response","volume":"71","author":"Gomes JA","year":"2003","unstructured":"Gomes JA, Bahia-Oliveira LM, Rocha MO, Martins-Filho OA, Gazzinelli G, Correa-Oliveira R. Evidence that development of severe cardiomyopathy in human Chagas' disease is due to a Th1-specific immune response. Infect Immun. 2003, 71:1185-93. 10.1128\/IAI.71.3.1185-1193.2003","journal-title":"Infect Immun"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2008.11.013","article-title":"Transforming growth factor beta 1 (TGFbeta1) gene polymorphisms and Chagas disease susceptibility in Peruvian and Colombian patients","volume":"45","author":"Calzada JE","year":"2009","unstructured":"Calzada JE, Bera\u00fan Y, Gonz\u00e1lez CI, Mart\u00edn J. Transforming growth factor beta 1 (TGFbeta1) gene polymorphisms and Chagas disease susceptibility in Peruvian and Colombian patients. Cytokine. 2009, 45:149-53. 10.1016\/j.cyto.2008.11.013","journal-title":"Cytokine"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2016.6831","article-title":"Inhibition of NFE2L2-antioxidant response element pathway by mitochondrial reactive oxygen species contributes to development of cardiomyopathy and left ventricular dysfunction in Chagas disease","volume":"27","author":"Wen JJ","year":"2017","unstructured":"Wen JJ, Porter C, Garg NJ. Inhibition of NFE2L2-antioxidant response element pathway by mitochondrial reactive oxygen species contributes to development of cardiomyopathy and left ventricular dysfunction in Chagas disease. Antioxid Redox Signal. 2017, 27:550-66. 10.1089\/ars.2016.6831","journal-title":"Antioxid Redox Signal"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.4161\/cc.10.7.15207","article-title":"Microarray analysis of the mammalian thromboxane receptor-Trypanosoma cruzi interaction","volume":"10","author":"Tanowitz HB","year":"2011","unstructured":"Tanowitz HB, Mukhopadhyay A, Ashton AW, Lisanti MP, Machado FS, Weiss LM, Mukherjee S. Microarray analysis of the mammalian thromboxane receptor-Trypanosoma cruzi interaction. Cell Cycle. 2011, 10:1132-43. 10.4161\/cc.10.7.15207","journal-title":"Cell Cycle"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00840","article-title":"Mast cell coupling to the kallikrein-kinin system fuels intracardiac parasitism and worsens heart pathology in experimental Chagas disease","volume":"8","author":"Nascimento CR","year":"2017","unstructured":"Nascimento CR, Andrade D, Carvalho-Pinto CE, et al.. Mast cell coupling to the kallikrein-kinin system fuels intracardiac parasitism and worsens heart pathology in experimental Chagas disease. Front Immunol. 2017, 8:840. 10.3389\/fimmu.2017.00840","journal-title":"Front Immunol"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1016\/j.idc.2012.03.002","article-title":"American trypanosomiasis (Chagas disease)","volume":"26","author":"Rassi A Jr","year":"2012","unstructured":"Rassi A Jr, Rassi A, Marcondes de Rezende J. American trypanosomiasis (Chagas disease). Infect Dis Clin North Am. 2012, 26:275-91. 10.1016\/j.idc.2012.03.002","journal-title":"Infect Dis Clin North Am"},{"key":"ref43","article-title":"Chagas disease: current perspectives on a forgotten disease","volume":"81","author":"\u00c1lvarez-Hern\u00e1ndez DA","year":"2018","unstructured":"\u00c1lvarez-Hern\u00e1ndez DA, Franyuti-Kelly GA, D\u00edaz-L\u00f3pez-Silva R, Gonz\u00e1lez-Ch\u00e1vez AM, Gonz\u00e1lez-Hermosillo-Cornejo D, V\u00e1zquez-L\u00f3pez R. Chagas disease: current perspectives on a forgotten disease. Rev Med Hosp Gen (Mex). 2018, 81:154-64.","journal-title":"Rev Med Hosp Gen (Mex)"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1410150","article-title":"Chagas' disease","volume":"373","author":"Bern C","year":"2015","unstructured":"Bern C. Chagas' disease. N Engl J Med. 2015, 373:456-66. 10.1056\/NEJMra1410150","journal-title":"N Engl J Med"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1111\/j.1542-474X.2006.00054.x","article-title":"Chronotropic incompetence and abnormal autonomic modulation in ambulatory Chagas disease patients","volume":"11","author":"Rocha AL","year":"2006","unstructured":"Rocha AL, Lombardi F, da Costa Rocha MO, Barros MV, Val Barros Vda C, Reis AM, Ribeiro AL. Chronotropic incompetence and abnormal autonomic modulation in ambulatory Chagas disease patients. Ann Noninvasive Electrocardiol. 2006, 11:3-11. 10.1111\/j.1542-474X.2006.00054.x","journal-title":"Ann Noninvasive Electrocardiol"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.110.082032","article-title":"Sustained ventricular tachycardia is associated with regional myocardial sympathetic denervation assessed with 123I-metaiodobenzylguanidine in chronic Chagas cardiomyopathy","volume":"52","author":"Miranda CH","year":"2011","unstructured":"Miranda CH, Figueiredo AB, Maciel BC, Marin-Neto JA, Sim\u00f5es MV. Sustained ventricular tachycardia is associated with regional myocardial sympathetic denervation assessed with 123I-metaiodobenzylguanidine in chronic Chagas cardiomyopathy. J Nucl Med. 2011, 52:504-10. 10.2967\/jnumed.110.082032","journal-title":"J Nucl Med"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.2008.159624","article-title":"Challenges and opportunities for primary, secondary, and tertiary prevention of Chagas' disease","volume":"95","author":"Rassi A Jr","year":"2009","unstructured":"Rassi A Jr, Dias JC, Marin-Neto JA, Rassi A. Challenges and opportunities for primary, secondary, and tertiary prevention of Chagas' disease. Heart. 2009, 95:524-34. 10.1136\/hrt.2008.159624","journal-title":"Heart"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1002\/clc.4960231205","article-title":"Chagas' heart disease","volume":"23","author":"Rassi A Jr","year":"2000","unstructured":"Rassi A Jr, Rassi A, Little WC. Chagas' heart disease. Clin Cardiol. 2000, 23:883-9. 10.1002\/clc.4960231205","journal-title":"Clin Cardiol"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.62.4.787","article-title":"M-mode and two-dimensional echocardiography in chronic Chages' heart disease. A clinical and pathologic study","volume":"62","author":"Acquatella H","year":"1980","unstructured":"Acquatella H, Schiller NB, Puigb\u00f3 JJ, et al.. M-mode and two-dimensional echocardiography in chronic Chages' heart disease. A clinical and pathologic study. Circulation. 1980, 62:787-99. 10.1161\/01.cir.62.4.787","journal-title":"Circulation"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1590\/s0100-879x2006000400008","article-title":"Minor segmental wall motion abnormalities detected in patients with Chagas' disease have adverse prognostic implications","volume":"39","author":"Pazin-Filho A","year":"2006","unstructured":"Pazin-Filho A, Romano MM, Almeida-Filho OC, et al.. Minor segmental wall motion abnormalities detected in patients with Chagas' disease have adverse prognostic implications. Braz J Med Biol Res. 2006, 39:483-7. 10.1590\/s0100-879x2006000400008","journal-title":"Braz J Med Biol Res"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1586\/14779072.2015.1103648","article-title":"Developments in the management of Chagas cardiomyopathy","volume":"13","author":"Tanowitz HB","year":"2015","unstructured":"Tanowitz HB, Machado FS, Spray DC, et al.. Developments in the management of Chagas cardiomyopathy. Expert Rev Cardiovasc Ther. 2015, 13:1393-409. 10.1586\/14779072.2015.1103648","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2008.09.012","article-title":"Changes in myocardial perfusion correlate with deterioration of left ventricular systolic function in chronic Chagas' cardiomyopathy","volume":"2","author":"Hiss FC","year":"2009","unstructured":"Hiss FC, Lascala TF, Maciel BC, Marin-Neto JA, Sim\u00f5es MV. Changes in myocardial perfusion correlate with deterioration of left ventricular systolic function in chronic Chagas' cardiomyopathy. JACC Cardiovasc Imaging. 2009, 2:164-72. 10.1016\/j.jcmg.2008.09.012","journal-title":"JACC Cardiovasc Imaging"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1590\/s0066-782x2007001800006","article-title":"Myocardial dysfunction in chagasic patients with no apparent heart disease","volume":"89","author":"Pinto Ade S","year":"2007","unstructured":"Pinto Ade S, Oliveira BM, Botoni FA, Ribeiro AL, Rocha MO. Myocardial dysfunction in chagasic patients with no apparent heart disease. Arq Bras Cardiol. 2007, 89:385-90. 10.1590\/s0066-782x2007001800006","journal-title":"Arq Bras Cardiol"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1016\/j.repc.2019.12.006","article-title":"Chagas cardiomyopathy and heart failure: from epidemiology to treatment","volume":"39","author":"Santos \u00c9","year":"2020","unstructured":"Santos \u00c9, Menezes Falc\u00e3o L. Chagas cardiomyopathy and heart failure: from epidemiology to treatment. Rev Port Cardiol (Engl Ed). 2020, 39:279-89. 10.1016\/j.repc.2019.12.006","journal-title":"Rev Port Cardiol (Engl Ed)"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1590\/s0066-782x2011000600002","article-title":"I Latin American Guidelines for the diagnosis and treatment of Chagas' heart disease: executive summary (Article in Portugese)","volume":"96","author":"Andrade JP","year":"2011","unstructured":"Andrade JP, Marin Neto JA, Paola AA, et al.. I Latin American Guidelines for the diagnosis and treatment of Chagas' heart disease: executive summary (Article in Portugese). Arq Bras Cardiol. 2011, 96:434-42. 10.1590\/s0066-782x2011000600002","journal-title":"Arq Bras Cardiol"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.0000163104.92943.50","article-title":"Chagasic cardiomyopathy is independently associated with ischemic stroke in Chagas disease","volume":"36","author":"Carod-Artal FJ","year":"2005","unstructured":"Carod-Artal FJ, Vargas AP, Horan TA, Nunes LG. Chagasic cardiomyopathy is independently associated with ischemic stroke in Chagas disease. Stroke. 2005, 36:965-70. 10.1161\/01.STR.0000163104.92943.50","journal-title":"Stroke"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.75.6.1140","article-title":"Cardiac morbidity and mortality due to Chagas' disease: prospective electrocardiographic study of a Brazilian community","volume":"75","author":"Maguire JH","year":"1987","unstructured":"Maguire JH, Hoff R, Sherlock I, et al.. Cardiac morbidity and mortality due to Chagas' disease: prospective electrocardiographic study of a Brazilian community. Circulation. 1987, 75:1140-5. 10.1161\/01.cir.75.6.1140","journal-title":"Circulation"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1016\/j.jelectrocard.2011.04.011","article-title":"The prognostic significance of electrocardiographic changes in Chagas disease","volume":"45","author":"Nascimento BR","year":"2012","unstructured":"Nascimento BR, Ara\u00fajo CG, Rocha MO, Domingues JD, Rodrigues AB, Barros MV, Ribeiro AL. The prognostic significance of electrocardiographic changes in Chagas disease. J Electrocardiol. 2012, 45:43-8. 10.1016\/j.jelectrocard.2011.04.011","journal-title":"J Electrocardiol"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1016\/s0167-5273(97)00083-1","article-title":"Clinical course of Chagas' heart disease: a comparison with dilated cardiomyopathy","volume":"60","author":"Bestetti RB","year":"1997","unstructured":"Bestetti RB, Muccillo G. Clinical course of Chagas' heart disease: a comparison with dilated cardiomyopathy. Int J Cardiol. 1997, 60:187-93. 10.1016\/s0167-5273(97)00083-1","journal-title":"Int J Cardiol"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.3855\/jidc.2576","article-title":"ELISA seroprevalence of Trypanosoma cruzi in a cohort of heart disease patients","volume":"7","author":"Rodriguez MV","year":"2013","unstructured":"Rodriguez MV, Hernandez WY, Garcia AN, Colato CM, Cardoza PG, Cardozo LM. ELISA seroprevalence of Trypanosoma cruzi in a cohort of heart disease patients. J Infect Dev Ctries. 2013, 7:348-54. 10.3855\/jidc.2576","journal-title":"J Infect Dev Ctries"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1016\/j.gheart.2015.07.001","article-title":"Electrocardiogram and Chagas disease: a large population database of primary care patients","volume":"10","author":"Marcolino MS","year":"2015","unstructured":"Marcolino MS, Palhares DM, Ferreira LR, Ribeiro AL. Electrocardiogram and Chagas disease: a large population database of primary care patients. Glob Heart. 2015, 10:167-72. 10.1016\/j.gheart.2015.07.001","journal-title":"Glob Heart"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0002078","article-title":"Electrocardiographic abnormalities in Trypanosoma cruzi seropositive and seronegative former blood donors","volume":"7","author":"Ribeiro AL","year":"2013","unstructured":"Ribeiro AL, Sabino EC, Marcolino MS, et al.. Electrocardiographic abnormalities in Trypanosoma cruzi seropositive and seronegative former blood donors. PLoS Negl Trop Dis. 2013, 7:e2078. 10.1371\/journal.pntd.0002078","journal-title":"PLoS Negl Trop Dis"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1111\/jce.12845","article-title":"The prevalence of atrial fibrillation and conduction abnormalities in Chagas disease: a meta-analysis","volume":"27","author":"Cardoso R","year":"2016","unstructured":"Cardoso R, Garcia D, Fernandes G, et al.. The prevalence of atrial fibrillation and conduction abnormalities in Chagas disease: a meta-analysis. J Cardiovasc Electrophysiol. 2016, 27:161-9. 10.1111\/jce.12845","journal-title":"J Cardiovasc Electrophysiol"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0006567","article-title":"Electrocardiographic abnormalities in Chagas disease in the general population: a systematic review and meta-analysis","volume":"12","author":"Rojas LZ","year":"2018","unstructured":"Rojas LZ, Glisic M, Pletsch-Borba L, et al.. Electrocardiographic abnormalities in Chagas disease in the general population: a systematic review and meta-analysis. PLoS Negl Trop Dis. 2018, 12:e0006567. 10.1371\/journal.pntd.0006567","journal-title":"PLoS Negl Trop Dis"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000079174.13444.9C","article-title":"Prognostic value of QT interval parameters for mortality risk stratification in Chagas' disease: results of a long-term follow-up study","volume":"108","author":"Salles G","year":"2003","unstructured":"Salles G, Xavier S, Sousa A, Hasslocher-Moreno A, Cardoso C. Prognostic value of QT interval parameters for mortality risk stratification in Chagas' disease: results of a long-term follow-up study. Circulation. 2003, 108:305-12. 10.1161\/01.CIR.0000079174.13444.9C","journal-title":"Circulation"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2004.01.040","article-title":"T-wave axis deviation as an independent predictor of mortality in chronic Chagas' disease","volume":"93","author":"Salles GF","year":"2004","unstructured":"Salles GF, Xavier SS, Sousa AS, Hasslocher-Moreno A, Cardoso CR. T-wave axis deviation as an independent predictor of mortality in chronic Chagas' disease. Am J Cardiol. 2004, 93:1136-40. 10.1016\/j.amjcard.2004.01.040","journal-title":"Am J Cardiol"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1016\/j.pcad.2009.11.008","article-title":"Chagas cardiomyopathy-where do we stand after a hundred years?","volume":"52","author":"Biolo A","year":"2010","unstructured":"Biolo A, Ribeiro AL, Clausell N. Chagas cardiomyopathy-where do we stand after a hundred years?. Prog Cardiovasc Dis. 2010, 52:300-16. 10.1016\/j.pcad.2009.11.008","journal-title":"Prog Cardiovasc Dis"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.106.627323","article-title":"Echocardiography in Chagas heart disease","volume":"115","author":"Acquatella H","year":"2007","unstructured":"Acquatella H. Echocardiography in Chagas heart disease. Circulation. 2007, 115:1124-31. 10.1161\/CIRCULATIONAHA.106.627323","journal-title":"Circulation"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1590\/s0066-782x2012005000031","article-title":"Delayed enhancement cardiac magnetic resonance imaging can identify the risk for ventricular tachycardia in chronic Chagas' heart disease","volume":"98","author":"Mello RP","year":"2012","unstructured":"Mello RP, Szarf G, Schvartzman PR, et al.. Delayed enhancement cardiac magnetic resonance imaging can identify the risk for ventricular tachycardia in chronic Chagas' heart disease. Arq Bras Cardiol. 2012, 98:421-30. 10.1590\/s0066-782x2012005000031","journal-title":"Arq Bras Cardiol"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2005.06.067","article-title":"Myocardial delayed enhancement by magnetic resonance imaging in patients with Chagas' disease: a marker of disease severity","volume":"46","author":"Rochitte CE","year":"2005","unstructured":"Rochitte CE, Oliveira PF, Andrade JM, et al.. Myocardial delayed enhancement by magnetic resonance imaging in patients with Chagas' disease: a marker of disease severity. J Am Coll Cardiol. 2005, 46:1553-8. 10.1016\/j.jacc.2005.06.067","journal-title":"J Am Coll Cardiol"},{"key":"ref71","article-title":"Nuclear medicine methods for assessment of chronic Chagas heart disease","volume":"33","author":"Sim\u00f5es MV","year":"2020","unstructured":"Sim\u00f5es MV, Tanaka DM, Marin-Neto JA. Nuclear medicine methods for assessment of chronic Chagas heart disease. Int J Cardiovasc Sci. 2020, 33:686-96.","journal-title":"Int J Cardiovasc Sci"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2015.07.040","article-title":"Inflammatory and cardiac biomarkers are differentially expressed in clinical stages of Chagas disease","volume":"199","author":"Keating SM","year":"2015","unstructured":"Keating SM, Deng X, Fernandes F, et al.. Inflammatory and cardiac biomarkers are differentially expressed in clinical stages of Chagas disease. Int J Cardiol. 2015, 199:451-9. 10.1016\/j.ijcard.2015.07.040","journal-title":"Int J Cardiol"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens10111493","article-title":"Molecular and clinical aspects of chronic manifestations in chagas disease: a state-of-the-art review","volume":"10","author":"Medina-Rinc\u00f3n GJ","year":"2021","unstructured":"Medina-Rinc\u00f3n GJ, Gallo-Bernal S, Jim\u00e9nez PA, et al.. Molecular and clinical aspects of chronic manifestations in chagas disease: a state-of-the-art review. Pathogens. 2021, 10:1493. 10.3390\/pathogens10111493","journal-title":"Pathogens"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2008.04.023","article-title":"Treatment of chronic systolic heart failure secondary to Chagas heart disease in the current era of heart failure therapy","volume":"156","author":"Bestetti RB","year":"2008","unstructured":"Bestetti RB, Theodoropoulos TA, Cardinalli-Neto A, Cury PM. Treatment of chronic systolic heart failure secondary to Chagas heart disease in the current era of heart failure therapy. Am Heart J. 2008, 156:422-30. 10.1016\/j.ahj.2008.04.023","journal-title":"Am Heart J"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2006.12.017","article-title":"A randomized trial of carvedilol after renin-angiotensin system inhibition in chronic Chagas cardiomyopathy","volume":"153","author":"Botoni FA","year":"2007","unstructured":"Botoni FA, Poole-Wilson PA, Ribeiro AL, et al.. A randomized trial of carvedilol after renin-angiotensin system inhibition in chronic Chagas cardiomyopathy. Am Heart J. 2007, 153:544.e1-8. 10.1016\/j.ahj.2006.12.017","journal-title":"Am Heart J"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.1002\/ehf2.12355","article-title":"Post hoc analyses of SHIFT and PARADIGM-HF highlight the importance of chronic Chagas' cardiomyopathy comment on: \"Safety profile and efficacy of ivabradine in heart failure due to Chagas heart disease: a post hoc analysis of the SHIFT trial\" by Bocchi et al","volume":"5","author":"Ramires FJ","year":"2018","unstructured":"Ramires FJ, Martinez F, G\u00f3mez EA, et al.. Post hoc analyses of SHIFT and PARADIGM-HF highlight the importance of chronic Chagas' cardiomyopathy comment on: \"Safety profile and efficacy of ivabradine in heart failure due to Chagas heart disease: a post hoc analysis of the SHIFT trial\" by Bocchi et al. ESC Heart Fail. 2018, 5:1069-71. 10.1002\/ehf2.12355","journal-title":"ESC Heart Fail"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.1007\/s40506-018-0170-z","article-title":"Treatment of Chagas disease in the United States","volume":"10","author":"Meymandi S","year":"2018","unstructured":"Meymandi S, Hernandez S, Park S, Sanchez DR, Forsyth C. Treatment of Chagas disease in the United States. Curr Treat Options Infect Dis. 2018, 10:373-88. 10.1007\/s40506-018-0170-z","journal-title":"Curr Treat Options Infect Dis"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/eut422","article-title":"Implantable cardioverter-defibrillators for treatment of sustained ventricular arrhythmias in patients with Chagas' heart disease: comparison with a control group treated with amiodarone alone","volume":"16","author":"Gali WL","year":"2014","unstructured":"Gali WL, Sarabanda AV, Baggio JM, Ferreira LG, Gomes GG, Marin-Neto JA, Junqueira LF. Implantable cardioverter-defibrillators for treatment of sustained ventricular arrhythmias in patients with Chagas' heart disease: comparison with a control group treated with amiodarone alone. Europace. 2014, 16:674-80. 10.1093\/europace\/eut422","journal-title":"Europace"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.1111\/pace.13333","article-title":"Long-term follow-up of Chagas heart disease patients receiving an implantable cardioverter-defibrillator for secondary prevention","volume":"41","author":"Pav\u00e3o ML","year":"2018","unstructured":"Pav\u00e3o ML, Arfelli E, Scorzoni-Filho A, et al.. Long-term follow-up of Chagas heart disease patients receiving an implantable cardioverter-defibrillator for secondary prevention. Pacing Clin Electrophysiol. 2018, 41:583-8. 10.1111\/pace.13333","journal-title":"Pacing Clin Electrophysiol"},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.1111\/pace.12342","article-title":"Long-term follow-up of patients with chronic chagas disease and implantable cardioverter-defibrillator","volume":"37","author":"Pereira FT","year":"2014","unstructured":"Pereira FT, Rocha EA, Monteiro Mde P, Neto AC, Daher Ede F, Sobrinho CR, Pires Neto Rda J. Long-term follow-up of patients with chronic chagas disease and implantable cardioverter-defibrillator. Pacing Clin Electrophysiol. 2014, 37:751-6. 10.1111\/pace.12342","journal-title":"Pacing Clin Electrophysiol"},{"key":"ref81","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2012.05.040","article-title":"Long-term follow-up of implantable cardioverter-defibrillator for secondary prevention in Chagas' heart disease","volume":"110","author":"Martinelli M","year":"2012","unstructured":"Martinelli M, de Siqueira SF, Sternick EB, Rassi A Jr, Costa R, Ramires JA, Kalil Filho R. Long-term follow-up of implantable cardioverter-defibrillator for secondary prevention in Chagas' heart disease. Am J Cardiol. 2012, 110:1040-5. 10.1016\/j.amjcard.2012.05.040","journal-title":"Am J Cardiol"},{"key":"ref82","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardfail.2008.10.023","article-title":"A systematic review of studies on heart transplantation for patients with end-stage Chagas' heart disease","volume":"15","author":"Bestetti RB","year":"2009","unstructured":"Bestetti RB, Theodoropoulos TA. A systematic review of studies on heart transplantation for patients with end-stage Chagas' heart disease. J Card Fail. 2009, 15:249-55. 10.1016\/j.cardfail.2008.10.023","journal-title":"J Card Fail"},{"key":"ref83","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2017.02.006","article-title":"Heart transplantation for Chagas cardiomyopathy","volume":"36","author":"Benatti RD","year":"2017","unstructured":"Benatti RD, Oliveira GH, Bacal F. Heart transplantation for Chagas cardiomyopathy. J Heart Lung Transplant. 2017, 36:597-603. 10.1016\/j.healun.2017.02.006","journal-title":"J Heart Lung Transplant"},{"key":"ref84","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2011.03444.x","article-title":"Screening and treatment of Chagas disease in organ transplant recipients in the United States: recommendations from the Chagas in transplant working group","volume":"11","author":"Chin-Hong PV","year":"2011","unstructured":"Chin-Hong PV, Schwartz BS, Bern C, et al.. Screening and treatment of Chagas disease in organ transplant recipients in the United States: recommendations from the Chagas in transplant working group. Am J Transplant. 2011, 11:672-80. 10.1111\/j.1600-6143.2011.03444.x","journal-title":"Am J Transplant"},{"key":"ref85","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.12120","article-title":"Parasitic infections in solid organ transplantation","volume":"13 Suppl 4","author":"Schwartz BS","year":"2013","unstructured":"Schwartz BS, Mawhorter SD. Parasitic infections in solid organ transplantation. Am J Transplant. 2013, 13 Suppl 4:280-303. 10.1111\/ajt.12120","journal-title":"Am J Transplant"},{"key":"ref86","doi-asserted-by":"publisher","DOI":"10.3390\/tropicalmed5030132","article-title":"Benznidazole as prophylaxis for Chagas disease infection reactivation in heart transplant patients: a case series in Brazil","volume":"5","author":"Rossi Neto JM","year":"2020","unstructured":"Rossi Neto JM, Finger MA, Dos Santos CC. Benznidazole as prophylaxis for Chagas disease infection reactivation in heart transplant patients: a case series in Brazil. Trop Med Infect Dis. 2020, 5:132. 10.3390\/tropicalmed5030132","journal-title":"Trop Med Infect Dis"},{"key":"ref87","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0028449","article-title":"Cardiac-oxidized antigens are targets of immune recognition by antibodies and potential molecular determinants in chagas disease pathogenesis","volume":"7","author":"Dhiman M","year":"2012","unstructured":"Dhiman M, Zago MP, Nunez S, et al.. Cardiac-oxidized antigens are targets of immune recognition by antibodies and potential molecular determinants in chagas disease pathogenesis. PLoS One. 2012, 7:e28449. 10.1371\/journal.pone.0028449","journal-title":"PLoS One"},{"key":"ref88","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/4396368","article-title":"The CXCL10\/CXCR3 axis and cardiac inflammation: Implications for immunotherapy to treat infectious and noninfectious diseases of the heart","volume":"2016","author":"Altara R","year":"2016","unstructured":"Altara R, Mallat Z, Booz GW, Zouein FA. The CXCL10\/CXCR3 axis and cardiac inflammation: Implications for immunotherapy to treat infectious and noninfectious diseases of the heart. J Immunol Res. 2016, 2016:4396368. 10.1155\/2016\/4396368","journal-title":"J Immunol Res"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/269977-unraveling-the-missing-pieces-exploring-the-gaps-in-understanding-chagas-cardiomyopathy","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,15]],"date-time":"2024-08-15T18:06:40Z","timestamp":1723745200000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/269977-unraveling-the-missing-pieces-exploring-the-gaps-in-understanding-chagas-cardiomyopathy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,15]]},"references-count":88,"URL":"https:\/\/doi.org\/10.7759\/cureus.66955","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8,15]]}}}